info@biofortuna.com
+44 151 334 0182

Board Directors

Nick is an experienced CEO with over 20 years’ experience in public listed and private companies operating internationally across the life sciences, healthcare diagnostic and biotechnology industries.

Prior to joining Biofortuna, Nick was CEO of Source BioScience plc, the Main Market-listed healthcare diagnostics and genomic services business, where he established operations in the US and Europe, growing revenues five fold.

Nick holds a PhD in Mycology and is a Chartered Accountant, qualifying with KPMG. Nick is also Chairman of Epistem Limited, the pre-clinical and clinical development CRO.

Nick Ash / CEO
Nick is an experienced Chief Operating Officer in the life sciences and healthcare diagnostic sectors.

Prior to joining Biofortuna, Nick was COO of Source BioScience plc, expanding the laboratory infrastructure from a single site in the UK to ten facilities worldwide. Before Source BioScience, Nick worked for over ten years in complex genetics and genomics, initially at Oxford University and then for the MRC at the Wellcome Trust Sanger Centre, subsequently Geneservice.

Nick qualified as a microbiologist and worked in the NHS, completing a PhD on the molecular methods used to characterise outbreaks of bacterial meningitis.

Nick Leaves / COO
Mark is a serial supporter of growth companies with a wealth of experience of start-up and early stage businesses. He is a director of a number of health and life science companies, whose technologies range from oncology therapeutic development through to medical devices for a range of applications including the management of metabolic disease.
Mark Hurley / Chairman
David Turner joined Foresight Group in 2018 and currently works as a Senior Investment Manager in the London office. He has over 14 years of experience. David is responsible for originating and executing new private equity investments. Prior to joining Foresight David worked at Stage Capital as an Investment Director where he focussed on making private equity investments in Europe. He has also worked as Corporate Development Manager at Experian plc, focussing on executing new investments globally for the group.

David holds a Masters Degree in Mechanical Engineering from Nottingham University and is a chartered accountant, having qualified with Grant Thornton in 2007.

David Turner / Senior Investment Manager
Do you have a project that we can help with? Contact us now to arrange an informal exploratory discussion.
I understand that Biofortuna will contact me and I will receive subsequent email updates (see Website Privacy Policy).